Rick King, VP at IAVI, To Present on HIV Vaccine Design at GTC's Vaccines Conf., July 8-10, Boston

Recent results of the RV144 trial suggest that a vaccine is possible and that the elicitation of antibody responses may be critical for activity.

http://www.pr-inside.com/rick-king-vp-at-iavi-to-r3674026.htm